Endocrine therapy leads the first- and second-line treatment options for hormone receptor-positive advanced breast cancer-comments on the Monarch plus study.

ABSTRACT:

SUBMITTER: Wang X 

PROVIDER: S-EPMC11093014 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature